A comparative single center, randomized neuropathic pain assessment study involving patients with clinically definite multiple sclerosis (MS) receiving treatment with either pregabalin [Lyrica] or paroxetine [Paxil].

Trial Profile

A comparative single center, randomized neuropathic pain assessment study involving patients with clinically definite multiple sclerosis (MS) receiving treatment with either pregabalin [Lyrica] or paroxetine [Paxil].

Completed
Phase of Trial: Phase III

Latest Information Update: 26 Jul 2012

At a glance

  • Drugs Paroxetine (Primary) ; Pregabalin (Primary)
  • Indications Neuropathic pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Jul 2012 Actual initiation date changed from Nov 2006 to Mar 2006 as reported by ClinicalTrials.gov.
    • 26 Jul 2012 Actual end date (Jul 2012) added as reported by ClinicalTrials.gov.
    • 01 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top